Center for Advancement of Blood Cancer Therapies

Icahn School of Medicine at Mount Sinai

12568 Citations
58 h-index
339 Article
46 Review article
18 Comment/debate
13 Letter
More

1₈ F-FLT PET and Blood-based Biomarkers for Identifying Gastrointestinal Graft versus Host Disease after Allogeneic Cell Transplantation
Holter-Chakrabarty, J., McNally, L., Levine, J., Ferrara, J., Vesely, S. K., Kanakry, C. G., Garwe, T., Han, Z., Pandey, M., Glover, J., Wen, Y., Gress, R. & Williams, K. M., 2025, In: Radiology: Imaging Cancer. 7, 1, e240096.
Research output: Contribution to journal › Article › peer-review

Open Access
2 Scopus citations
A heterozygous CEBPA mutation disrupting the bZIP domain in a RUNX1 and SRSF2 mutational background causes MDS disease progression
Almaghrabi, R., Alyahyawi, Y., Keane, P., Mian, S. A., Habel, K., Atkinson, A., Ward, C., Bayley, R., Sargas, C., Menendez, P., Murphy, G. J., Sobahy, T., Baghdadi, M. A., Flemban, A. F., Kabrah, S. M., Torres-Ruiz, R., Papapetrou, E. P., Akerman, I., Raghavan, M. & Barragan, E. & 3 others, Bonnet, D., Bonifer, C. & Garcia, P., Dec 2025, In: Nature Communications. 16, 1, 5489.
Research output: Contribution to journal › Article › peer-review

Open Access
A map of enhancer regions in primary human neural progenitor cells using capture STARR-seq
PsychENCODE Consortium, Aug 2025, In: Genome Research. 35, 8, p. 1887-1901 15 p.
Research output: Contribution to journal › Article › peer-review

1 Scopus citations
An inflammatory state defines a high-risk T-lineage acute lymphoblastic leukemia subgroup
Gower, M., Li, X., Aguilar-Navarro, A. G., Lin, B., Fernandez, M., Edun, G., Nader, M., Rondeau, V., Arruda, A., Tierens, A., Seffernick, A. E., Pölönen, P., Durocher, J., Wagenblast, E., Yang, L., Lee, H. S., Mullighan, C. G., Teachey, D., Rashkovan, M. & Tremblay, C. S. & 14 others, Herranz, D., Itkin, T., Loghavi, S., Dick, J. E., Schwartz, G., Perusini, M. A., Sibai, H., Hitzler, J., Gruber, T. A., Minden, M., Jones, C. L., Dolgalev, I., Jahangiri, S. & Tikhonova, A. N., 1 Jan 2025, In: Science Translational Medicine. 17, 779, eadr2012.
Research output: Contribution to journal › Article › peer-review
5 Scopus citations
An integrated approach for the accurate detection of HERV-K HML-2 transcription and protein synthesis
Gleason, C., Terry, S. N., Hernandez, M. M., Jacob, S., Fenyo, D., Johnson, J. R., Deikus, G., Francoeur, N., Hahn, A., Sebra, R., Zamarin, D., Molina, H., Simon, V. & Mulder, L. C. F., 27 Jan 2025, In: Nucleic Acids Research. 53, 2, gkaf011.
Research output: Contribution to journal › Article › peer-review

Open Access
A novel 3-way translocation involving ETV6::IL3 drives AML with eosinophilia
Siegel, A., Tripodi, J., Hardatt, D., Kelly, B., El Ghaity-Beckley, S., Becker, M., Francisco, B., Bailey, K., Petersen, B., Tremblay, D., Feld, J., Levavi, H., Kremyanskaya, M., Keyzner, A., Marcellino, B. K., Salib, C., Duffield, A. S., Mascarenhas, J., Najfeld, V. & Shih, A. H., May 2025, In: Blood Neoplasia. 2, 2, 100079.
Research output: Contribution to journal › Article › peer-review

Open Access
A patient-derived T cell lymphoma biorepository uncovers pathogenetic mechanisms and host-related therapeutic vulnerabilities
Fiore, D., Cappelli, L. V., Zhaoqi, L., Kotlov, N., Sorokina, M., Phillip, J., Zumbo, P., Yoffe, L., Ghione, P., Wang, A., Han, X., Taylor, A., Chiu, W., Fragliasso, V., Tabbo, F., Zamponi, N., Di Siervi, N., Kayembe, C., Medico, G. & Patel, R. P. & 57 others, Gaudiano, M., Machiorlatti, R., Astone, G., Cacciapuoti, M. T., Zanetti, G., Pignataro, C., Eric, R. A., Patel, S., Zammarchi, F., Zanettini, C., Queiroz, L., Nikitina, A., Kudryashova, O., Karelin, A., Nikitin, D., Tychinin, D., Postovalova, E., Bagaev, A., Svekolkin, V., Belova, E., Tikhonova, K., Degryse, S., Xu, C., Novero, D., Ponzoni, M., Tiacci, E., Falini, B., Song, J., Khodos, I., De Stanchina, E., Macari, G., Cafforio, L., Gardini, S., Piva, R., Medico, E., Ng, S. Y., Moskowitz, A., Epstein, Z., Intlekofer, A., Ahmed, D., Chan, W. C., Martin, P., Ruan, J., Bertoni, F., Foà, R., Brody, J. D., Weinstock, D. M., Osan, J., Santambrogio, L., Elemento, O., Betel, D., Tam, W., Ruella, M., Cerchietti, L., Rabadan, R., Horwitz, S. & Inghirami, G., 15 Apr 2025, In: Cell Reports Medicine. 6, 4, 102029.
Research output: Contribution to journal › Article › peer-review

Open Access
2 Scopus citations
A streamlined base editor engineering strategy to reduce bystander editing
Valdez, I., O’Connor, I., Patel, D., Gierer, K., Harrington, J., Ellis, E., Caponetti, S. A., Sebra, R. P., Valley, H. C., Coote, K., Mense, M., Marro, S. G. & Jiang, T., Dec 2025, In: Nature Communications. 16, 1, 8115.
Research output: Contribution to journal › Article › peer-review

Open Access

2 Scopus citations
A study of gene expression in the living human brain
Liharska, L. E., Park, Y. J., Ziafat, K., Wilkins, L., Silk, H., Linares, L. M., Thompson, R. C., Vornholt, E., Sullivan, B., Cohen, V., Kota, P., Feng, C., Cheng, E., Johnson, J. S., Rieder, M. K., Huang, J., Scarpa, J., Polanco, J., Moya, E. & Hashemi, A. & 8 others, Levin, M. A., Nadkarni, G. N., Sebra, R., Crary, J. F., Schadt, E. E., Beckmann, N. D., Kopell, B. H. & Charney, A. W., 2025, (Accepted/In press) In: Molecular Psychiatry.
Research output: Contribution to journal › Article › peer-review

Open Access

1 Scopus citations
Atezolizumab plus personalized neoantigen vaccination in urothelial cancer: a phase 1 trial
Saxena, M., Anker, J. F., Kodysh, J., O’Donnell, T., Kaminska, A. M., Meseck, M., Hapanowicz, O., Niglio, S. A., Salazar, A. M., Shah, H. R., Kinoshita, Y., Brody, R., Rubinsteyn, A., Sebra, R. P., Bhardwaj, N. & Galsky, M. D., Jun 2025, In: Nature Cancer. 6, 6, p. 988-999 12 p.
Research output: Contribution to journal › Article › peer-review
5 Scopus citations
At the cusp of a cure in Myeloma: Insights into pathogenesis, modeling and therapeutics
Parekh, S., Feb 2025, In: Seminars in Hematology. 62, 1, p. 1-2 2 p.
Research output: Contribution to journal › Editorial
Author Correction: A streamlined base editor engineering strategy to reduce bystander editing (Nature Communications, (2025), 16, 1, (8115), 10.1038/s41467-025-63609-6)
Valdez, I., O’Connor, I., Patel, D., Gierer, K., Harrington, J., Ellis, E., Caponetti, S. A., Sebra, R. P., Valley, H. C., Coote, K., Mense, M., Marro, S. G. & Jiang, T., Dec 2025, In: Nature Communications. 16, 1, 9787.
Research output: Contribution to journal › Comment/debate

Open Access

Purple Biotech Reports Positive New Preclinical Data Demonstrating Multi-Arm Anti-Tumor Activity Across Two CAPTN-3 Tri-Specific Antibodies at ESMO Immuno-Oncology Congress 2025 | PPBT Stock News
Horowitz, A.
11/12/25
1 item of Media coverage
Press/Media
Mount Sinai Study Finds Childhood Leukemia Aggressiveness Depends on Timing of Genetic Mutation
Wagenblast, E.
8/12/25
1 item of Media coverage
Press/Media
Weekly Summary: Karyopharm Therapeutics (KPTI: $4.55) lifts 3.6%, 5 weeks' volume in a week; +16c [3.6%] Vol Index 5.0 [1 is avg]
Mascarenhas, J.
12/07/25
1 item of Media coverage
Press/Media
Findings from Icahn School of Medicine at Mount Sinai in the Area of Acute Myeloid Leukemia Described (Exclusion of Acute Myeloid Leukemia Patients With Central Nervous System Involvement From Clinical Trials: an Analysis of the National ...)
Sastow , D., Tremblay, D., Kremyanskaya, M. & Mascarenhas, J.
9/07/25
1 item of Media coverage
Press/Media
University of Washington Reports Findings in Cystic Fibrosis (Clinical Effectiveness of Elexacaftor/Tezacaftor/Ivacaftor in 6 to 11-Year-Olds with Cystic Fibrosis)
Hoffman, R.
8/07/25
1 item of Media coverage
Press/Media
Weekly Summary: Karyopharm Therapeutics (KPTI: $4.39) drops 2.2% on below average volume; -10c [2.2%]
Mascarenhas, J.
7/07/25
1 item of Media coverage
Press/Media
Top Oncology Videos for the Week of 6/29
Mascarenhas, J.
6/07/25
1 item of Media coverage
Press/Media
Monthly: Karyopharm Therapeutics (KPTI: $4.31) increases 3% on thin volume in June 2025
Mascarenhas, J.
1/07/25
1 item of Media coverage
Press/Media
Weekly Summary: Karyopharm Therapeutics (KPTI: $4.39) increases on weak volume; +1c [0.2%]
Mascarenhas, J.
28/06/25
1 item of Media coverage
Press/Media
Weekly: Karyopharm Therapeutics (KPTI: $4.38) increases 0.5% on weak volume; +2c [0.5%]
Mascarenhas, J.
21/06/25
1 item of Media coverage
Press/Media
Positive Late-Breaking Data for Incyte's First-in-Class mutCALR-targeted therapy INCA033989 in Essential Thrombocythemia Presented at EHA2025
Mascarenhas, J.
15/06/25 → 16/06/25
19 items of Media coverage
Press/Media
Incyte : MPN Data Highlights from EHA 2025
Mascarenhas, J.
15/06/25
1 item of Media coverage
Press/Media